Myriad Genetics Stock Price History

MYGN Stock  USD 4.47  0.35  7.26%   
Below is the normalized historical share price chart for Myriad Genetics extending back to October 06, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Myriad Genetics stands at 4.47, as last reported on the 20th of July, with the highest price reaching 4.92 and the lowest price hitting 4.46 during the day.
IPO Date
5th of October 1995
200 Day MA
11.8193
50 Day MA
4.805
Beta
1.854
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Myriad Stock, it is important to understand the factors that can impact its price. Myriad Genetics has Sharpe Ratio of -0.0781, which conveys that the firm had a -0.0781 % return per unit of risk over the last 3 months. Myriad Genetics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Myriad Genetics' Mean Deviation of 3.96, standard deviation of 6.57, and Risk Adjusted Performance of (0.08) to check out the risk estimate we provide.
As of the 20th of July 2025, Other Stockholder Equity is likely to grow to about 1.5 B, while Total Stockholder Equity is likely to drop about 537.8 M. . As of the 20th of July 2025, Price To Sales Ratio is likely to drop to 1.41. In addition to that, Price Earnings Ratio is likely to grow to -9.27. Myriad Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0781

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMYGN

Estimated Market Risk

 6.7
  actual daily
60
60% of assets are less volatile

Expected Return

 -0.52
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Myriad Genetics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Myriad Genetics by adding Myriad Genetics to a well-diversified portfolio.
Price Book
0.5845
Enterprise Value Ebitda
(23.47)
Price Sales
0.4956
Shares Float
89.8 M
Wall Street Target Price
7.6154

Myriad Genetics Stock Price History Chart

There are several ways to analyze Myriad Stock price data. The simplest method is using a basic Myriad candlestick price chart, which shows Myriad Genetics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMay 5, 20257.7
Lowest PriceMay 14, 20253.84

Myriad Genetics July 20, 2025 Stock Price Synopsis

Various analyses of Myriad Genetics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Myriad Stock. It can be used to describe the percentage change in the price of Myriad Genetics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Myriad Stock.
Myriad Genetics Price Daily Balance Of Power(0.76)
Myriad Genetics Price Rate Of Daily Change 0.93 
Myriad Genetics Price Action Indicator(0.40)

Myriad Genetics July 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Myriad Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Myriad Genetics intraday prices and daily technical indicators to check the level of noise trading in Myriad Stock and then apply it to test your longer-term investment strategies against Myriad.

Myriad Stock Price History Data

The price series of Myriad Genetics for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 4.24 with a coefficient of variation of 23.32. The daily prices for the period are spread out with arithmetic mean of 5.46. The median price for the last 90 days is 5.18. The company underwent 2:1 stock split on 26th of March 2009.
OpenHighLowCloseVolume
07/20/2025
 4.88  4.92  4.46  4.47 
07/18/2025 4.88  4.92  4.46  4.47  1,361,987 
07/17/2025
 5.04  5.10  4.78  4.82  1,124,709 
07/16/2025
 5.07  5.20  4.99  5.06  2,925,985 
07/15/2025 5.28  5.37  4.97  5.00  1,654,503 
07/14/2025
 5.29  5.35  5.18  5.22  810,505 
07/11/2025 5.45  5.59  5.32  5.34  888,124 
07/10/2025
 5.71  5.83  5.43  5.50  1,381,830 
07/09/2025
 5.60  5.72  5.49  5.72  963,748 
07/08/2025
 5.29  5.56  5.25  5.55  980,955 
07/07/2025
 5.58  5.61  5.25  5.29  1,381,960 
07/03/2025
 5.63  5.70  5.54  5.60  463,756 
07/02/2025
 5.55  5.72  5.47  5.63  1,386,226 
07/01/2025
 5.26  5.74  5.23  5.53  1,432,696 
06/30/2025
 5.23  5.38  5.21  5.31  907,164 
06/27/2025 5.35  5.50  5.17  5.25  1,881,072 
06/26/2025
 5.09  5.35  5.09  5.33  1,046,750 
06/25/2025 5.03  5.20  4.90  5.12  1,049,187 
06/24/2025
 4.93  5.10  4.93  5.05  1,222,780 
06/23/2025
 4.86  4.95  4.76  4.86  1,282,457 
06/20/2025
 5.14  5.14  4.90  4.92  3,159,244 
06/18/2025
 4.96  5.29  4.91  5.07  1,987,368 
06/17/2025 4.90  5.24  4.78  4.98  1,908,731 
06/16/2025
 5.04  5.08  4.86  4.92  1,673,371 
06/13/2025
 5.15  5.20  5.03  5.03  1,304,023 
06/12/2025
 5.14  5.26  5.06  5.19  1,247,604 
06/11/2025
 5.27  5.34  5.06  5.18  1,236,235 
06/10/2025 5.19  5.32  5.10  5.23  1,668,292 
06/09/2025
 5.19  5.37  5.15  5.19  2,157,587 
06/06/2025 4.93  5.17  4.93  5.09  1,686,163 
06/05/2025
 5.28  5.29  4.90  4.92  2,577,165 
06/04/2025
 4.90  5.40  4.89  5.29  3,329,725 
06/03/2025 4.46  4.96  4.36  4.88  4,134,070 
06/02/2025
 4.24  4.52  4.17  4.46  2,909,879 
05/30/2025 4.09  4.24  3.99  4.19  2,423,007 
05/29/2025
 4.34  4.35  4.08  4.16  1,656,502 
05/28/2025
 4.13  4.38  4.10  4.33  2,871,372 
05/27/2025
 3.95  4.17  3.95  4.15  2,371,302 
05/23/2025
 3.86  3.96  3.86  3.91  1,612,910 
05/22/2025 4.04  4.08  3.91  3.93  2,313,697 
05/21/2025
 4.25  4.36  4.07  4.07  2,153,277 
05/20/2025
 4.35  4.51  4.34  4.45  1,818,396 
05/19/2025
 4.13  4.47  4.12  4.43  2,356,582 
05/16/2025
 4.12  4.18  4.05  4.13  2,193,239 
05/15/2025
 3.88  4.12  3.81  4.11  2,353,746 
05/14/2025
 4.11  4.22  3.84  3.84  3,510,985 
05/13/2025
 4.25  4.31  4.08  4.11  3,594,184 
05/12/2025 4.00  4.26  3.83  4.25  3,667,474 
05/09/2025
 4.09  4.23  3.86  3.89  3,863,117 
05/08/2025 4.29  4.31  3.98  4.03  7,291,329 
05/07/2025
 5.70  5.82  4.24  4.27  12,601,109 
05/06/2025
 7.65  7.81  7.24  7.27  2,938,681 
05/05/2025
 7.55  7.78  7.36  7.70  1,543,777 
05/02/2025
 7.27  7.66  7.21  7.56  2,311,317 
05/01/2025
 7.44  7.48  6.94  7.13  3,944,606 
04/30/2025
 7.16  7.55  7.11  7.41  4,218,000 
04/29/2025
 7.49  7.56  7.17  7.20  1,625,170 
04/28/2025
 7.44  7.71  7.30  7.50  1,973,259 
04/25/2025
 7.31  7.43  7.16  7.42  2,666,862 
04/24/2025
 7.37  7.46  7.22  7.37  2,492,767 
04/23/2025
 7.78  7.89  7.27  7.29  2,072,730 

About Myriad Genetics Stock history

Myriad Genetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Myriad is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Myriad Genetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Myriad Genetics stock prices may prove useful in developing a viable investing in Myriad Genetics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding90.6 M75.8 M
Net Income Applicable To Common Shares202.7 M159.7 M

Myriad Genetics Quarterly Net Working Capital

136.1 Million

Myriad Genetics Stock Technical Analysis

Myriad Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Myriad Genetics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Myriad Genetics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

Myriad Genetics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Myriad Genetics' price direction in advance. Along with the technical and fundamental analysis of Myriad Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Myriad to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Myriad Genetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myriad Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myriad Genetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myriad Genetics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
9.138
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.05)
Return On Equity
(0.14)
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.